4//SEC Filing
Reeve Emma 4
Accession 0001680329-25-000010
CIK 0001070081other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:20 PM ET
Size
8.7 KB
Accession
0001680329-25-000010
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Sale
Common Stock
2025-11-12$74.50/sh−7,333$546,309→ 6,666 total - Exercise/Conversion
Common Stock
2025-11-12$46.54/sh+7,333$341,278→ 13,999 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−7,333→ 1,467 totalExercise: $46.54Exp: 2035-01-02→ Common Stock (7,333 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F2]This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001680329
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:20 PM ET
- Size
- 8.7 KB